PET/MRI in Oncology: Real-World Recommendations
Year: 2026
Type: article
Abstract: Positron emission tomography/magnetic resonance imaging (PET/MRI) has represented a paradigm shift in medical imaging, and although its use has not yet been fully incorporated into all clinical guidelines, scientific evidence supports its ability to provide a highly accurate simultaneous metabolic and anatomical assessment, which is particularly useful for staging, treatment planning, and evaluating treatment response in cancer patients. The limited availability of the technique and the demands it places on resources and coordination suggest that its initial use should focus on those applications that can provide the greatest benefit to patients, especially within the indications related to oncological processes, where PET and MRI have a defined and complementary role. This review focuses specifically on some of these conditions.
Source: Cancers
Institutions: Servicio de Salud de Castilla La Mancha, Hospital Universitario de Toledo, Hospital Universitario HM Madrid, HM Hospitales, Itron (United States), Bellvitge University Hospital, Institut de Diagnòstic per la Imatge, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7225224022
FWCI:
Cites:
Cited by:
Related to: